Skip to main content
Log in

Tissue Tolerance of Intramuscular Injectables and Plasma Enzyme Activities in Rats

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The local tissue damage after intramuscular injection caused by various commercially available injection solutions was determined in the albino rat, by measuring plasma activities of creatine phosphokinase, aspartate aminotransferase, and lactic dehydrogenase, the tissue activity of creatine phosphokinase, and macroscopic changes in the muscle at the injection site (gastrocnemius muscle). The plasma enzyme activities were determined 2, 6, 18, and 28 hr after the injection. After 28 hr the animals were sacrificed for macroscopic inspection of the injection site and for the determination of tissue enzyme activity. The tissue injury caused by the test substances correlated well with the elevated creatine phosphokinase activity (2 hr). The elevations of aspartate aminotransferase (18 hr) and lactate dehydrogenase (2 hr) activity as well as the loss of tissue creatine phosphokinase activity were less indicative of differences between test preparations. The i.p. administration of some of the test preparations caused increased enzyme activity without muscle damage, which could interfere with the test results. The creatine phosphokinase determination indicates the damage occurring immediately after the administration of the test solution, and the macroscopic inspection offers the possibility to obtain some information on the evolution of the muscular lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. K. F. Benitz and G. Dambach. Arzneimittelforsch 16:658–661 (1966).

    Google Scholar 

  2. G. Kienel. Arzneimittelforsch 23:263–266 (1973).

    Google Scholar 

  3. G. Machnik, O. Löw, H. Schicketanz, and G. Simon. Zbl. Pharm. 110:913–941 (1971).

    Google Scholar 

  4. O. Löw, G. Machnik, G. Simon, and H. Schicketanz. Exp. Pathol. 8:128–136 (1973).

    Google Scholar 

  5. S. Shintani, M. Yamazaki, M. Nakamura, and I. Nakayama. Toxicol. Appl. Pharmacol. 11:293–301 (1967).

    Google Scholar 

  6. E. Steiness, F. Rasmussen, O. Svendsen, and P. Nielsen. Acta Pharmacol. Toxicol. 42:357–364 (1978).

    Google Scholar 

  7. H. O. Gloor, C. Vorburger, and J. Schädelin. Schweiz. Med. Wschr. 107:948–952 (1977).

    Google Scholar 

  8. T. P. Johnston and S. C. Miller. J. Parent. Sci. Technol. 39:83–88 (1985).

    Google Scholar 

  9. J. E. Gray. In J. R. Robinson (ed.), Sustained and Controlled Release Drug Delivery Systems, Marcel Dekker, New York, 1978, pp. 351–410.

    Google Scholar 

  10. O. Svendsen, F. Rasmussen, P. Nielsen, and E. Steiness. Acta Pharmacol. Toxicol. 44:324–328 (1979).

    Google Scholar 

  11. W. P. Cockshott, G. T. Thompson, L. J. Howlett, and E. T. Seeley. N. Engl. J. Med. 307:356–358 (1982).

    Google Scholar 

  12. G. E. Paget and H. McScott. Br. J. Pharmacol. Chemother. 12:426 (1957).

    Google Scholar 

  13. P. Keller. Kleintier Praxis. 24:51–68 (1979).

    Google Scholar 

  14. J. H. Wilkinson. Clin. Chem. 16:882–890 (1970).

    Google Scholar 

  15. J. E. Gray, R. N. Weaver, J. Moran, and E. S. Feenstra. Toxicol. Appl. Pharmacol. 27:308–321 (1974).

    Google Scholar 

  16. H. Y. Meltzer. Biochem. Pharmacol. 20:1739–1748 (1971).

    Google Scholar 

  17. C. Surber. Thesis, University of Basel, Basel, 1984.

  18. H. Hsu and J. Watanabe. Chem. Pharm. Bull. 29:3350–3355 (1981).

    Google Scholar 

  19. K. Hirano, T. Ichikashi, and H. Yamada. Chem. Pharm. Bull. 29:519–531 (1981).

    Google Scholar 

  20. SAS Institute Inc. SAS User's Guide: Statistics, SAS, Cary, N.C., 1985.

    Google Scholar 

  21. S. Holm. Scand. J. Stat. 6:65–70 (1979).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Surber, C., Sucker, H. Tissue Tolerance of Intramuscular Injectables and Plasma Enzyme Activities in Rats. Pharm Res 4, 490–494 (1987). https://doi.org/10.1023/A:1016427605545

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016427605545

Navigation